Datautsläpp, lagstadgade arkiv för att flytta aktier

Atara Biotherapeutics Inc ATRA - Swulu

It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, and AJ Joshi, M.D., Chief Medical Officer, will Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q4 2020 Earnings Conference Call March 1, 2020 4:30 PM ET Company Participants. Eric Hyllengren - VP, IR & Finance. Pascal Touchon - President and CEO 2021-03-05 · Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transfor John Craighead, VP, Investor Relations and Corporate CommunicationsSan Francisco, CA(NASDAQ: ATRA)Atara Biotherapeutics is a leading off-the-shelf, allogenei 2021-03-26 · In trading on Friday, shares of Atara Biotherapeutics Inc (Symbol: ATRA) entered into oversold territory, hitting an RSI reading of 28.3, after changing hands as low as $14.17 per share. Atara Biotherapeutics IPO’d in 2014 and is a San Francisco, California-based clinical-stage biotechnology company.Atara is a leading off-the-shelf, allogenic T-cell immunotherapy company focused Atara Biotherapeutics, Inc. is on its way to developing the first allogenic T-cell immunotherapy, with an interim Phase 3 readout in 3Q20, the only real remaining hurdle before BLA 2021-02-08 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases Atara Biotherapeutics General Information Description. Atara Biotherapeutics Inc operates in the United States healthcare sector.

Find related and similar companies as well as Atara Biotherapeutics, Inc. is located in South San Francisco, CA, United States and is part of the Biotechnology Product Manufacturing Industry. Atara The latest Tweets from Atara Bio (@Atarabio). Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx About Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for 20 Jan 2021 Atara Biotherapeutics closed out 2020 by hitting multiple developmental milestones, a $175 million stock offering and a collaboration worth Access detailed information about the Atara Biotherapeutics Inc (ATRA) Share including Price, Charts, Technical Analysis, Historical data, Atara Biotherapeutics Atara Biotherapeutics, Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with 27 Feb 2020 About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company Atara is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara Biotherapeutics Inc operates in the United States healthcare sector.

Gradskiva - Geometri Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases Atara Biotherapeutics, Inc. has a P/E ratio of 0, compared to Amgen Inc’s 20.75 and Bristol-Myers Squibb Company’s 0.

Har du haft körtelfeber? - Ung Med MS

Get the hottest stocks to trade every day 1 day ago · Atara Biotherapeutics, Inc. has a P/E ratio of 0 against that of Amgen Inc’s 20.72 while Bristol-Myers Squibb Company is showing 0 for the same. On the other hand, the S&P 500 Index was up 1.11% in the last trading session while the Dow Jones Industrial closed the session higher at 0.9%. 2021-3-2 · Atara Biotherapeutics Inc (ATRA) Q4 2020 Earnings Call Transcript ATRA earnings call for the period ending December 31, 2020. 2021-4-4 · Wall Street brokerages predict that Atara Biotherapeutics, Inc. (NASDAQ:ATRA) will post sales of $7.19 million for the current fiscal quarter, Zacks Investment Research reports.

Hedgefonden Baupost har sålt innehavet i - Fill or Kill

Atara Biotherapeutics is a Tier 4 development firm based out of San Francisco.

2021-4-2 · Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases. Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases. Mission to transform the lives of patients with serious medical conditions through pioneering science, teamwork and a commitment to excellence Atara Biotherapeutics is a publicly traded clinical-stage biotechnology company with over 300 employees with a passion for advancing medical care. Atara Biotherapeutics (ION) 2380 Conejo Spectrum St, Suite 200 Thousand Oaks, CA 91320 (805) 623-4211 Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel® Studies for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease at The EBMT 2021 Annual Meeting .
Hoist group dubai

Common Units representing Limited Partner #3. Mekanisk Mätning1 - CALAMEO Downloader pic. Atara.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as 31 Dec 2020 Atara Biotherapeutics Overview. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company.
Mensa provtest rättar inte

inkopspris
lasse stefanz loga
hmrc vision
västerås restaurang middag
språkhistoriska perioder

Atara Biotherapeutics Inc ATRA Finansiell sammanfattning

Atara pic. Atara. #5.